CHAPERONE FUNCTION AND VASCULAR AGING
CHAPERONE FUNCTION AND VASCULAR AGING
批准号:
7646313
负责人:
WINSTON C PATTERSON
金额:
$38.89万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAgeAgingAging-Related ProcessApolipoprotein EApoptosisArterial Fatty StreakAtherosclerosisAttentionAttenuatedBiologicalBiologyBlood VesselsCell ProliferationCell RespirationCell physiologyCellsCellular StressChronicCoronary ArteriosclerosisDataDefectDiffuseEquilibriumEventExtracellular MatrixFunctional disorderGeneticHeat shock proteinsImpairmentIn VitroInflammationInflammatoryInjuryInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorKyphosis deformity of spineLesionLinkLongevityMethodsModelingMolecularMolecular ChaperonesMusMutant Strains MiceOxidative StressPhenotypePlayPopulationPortraitsPredispositionPrevalencePrincipal InvestigatorProcessProtein DeficiencyProteinsRegulationRisk FactorsRoleSOD2 geneSignal TransductionSmooth Muscle MyocytesStressSystemTestingTissuesUC01Workage effectage relatedatherogenesisbiological adaptation to stresschaperone machineryin vivoin vivo Modelmouse Smc1l1 proteinmouse Smc1l2 proteinnovelprogramsprotein foldingresponsesenescencesuperoxide dismutase 1tooltranscription factorubiquitin ligase
中文摘要
冠状动脉疾病的患病率随着年龄的增长而增加,年龄本身是动脉粥样硬化形成的独立危险因素。对细胞应激的敏感性增加和血管组织损伤的累积可能是衰老引起的动脉粥样硬化环境中的因素,但导致动脉粥样硬化病变形成的年龄相关事件的确切分子过程仍有待确定。
我们最近的数据表明,小鼠提供了一个很好的模型来了解衰老对血管壁生物学的内在影响,这些生物学有助于动脉粥样硬化过程。我们也开始考虑细胞伴侣机制在细胞应激反应中的一般作用,特别是这些事件可能与动脉粥样硬化病变形成有关。特别是,我们最近克隆和表征了一种新的共伴侣蛋白/泛素连接酶,CHIP(Hsc 70相互作用蛋白的羧基末端),并已确定了一个令人惊讶的核心作用,这种蛋白质在平衡蛋白质折叠和降解,并通过其激活关键的应激调节转录因子HSF 1的能力来调节应激反应。作为
为了证明CHIP在与血管老化相关的应激反应事件中具有核心作用,我们已经产生了CHIP缺陷的小鼠,其具有受损的应激反应和与加速老化一致的许多特征。我们现在将开始探索在本建议中连接这些过程的分子事件。为此,我们提出了四个目标:具体目标#1--确定CHIP缺乏对衰老相关表型的影响;具体目标#2--确定体外血管平滑肌细胞中CHIP缺乏的细胞后果;具体目标#3--确定细胞应激调节对体内血管表型和动脉粥样硬化形成的作用;具体目标#4-检查伴侣的相互作用
氧化代谢和IGF-1信号系统。这些研究将描绘伴侣功能障碍、慢性氧化损伤和IGF-1信号传导改变之间的相互作用,这些改变决定了血管对衰老的反应。
英文摘要
The prevalence of coronary artery disease increases with age, and age itself is an independent risk factor for atherogenesis. Increased susceptibility to cellular stress and accrual of damage to vascular tissues are likely factors in the atherogenic milieu attributable to aging, yet the precise molecular processes underlying the age-associated events culminating in atherosclerotic lesion formation remain to be determined.
Our recent data indicate that mice provide an excellent model for understanding the intrinsic effects of aging on vascular wall biology that contribute to the atherogenic process. We have also begun to consider the general role of the cellular chaperone machinery in the cell stress response, particularly as these events may be relevant to atherosclerotic lesion formation. In particular, we have recently cloned and characterized a novel co-chaperone/ubiquitin ligase, CHIP (carboxyl terminus of Hsc70-interacting protein), and have identified a surprising central role for this protein in balancing protein folding and degradation and regulating the stress response through its ability to activate the crucial stress-regulatory transcription factor HSF1. As
proof that CHIP has a central role in stress-responsive events relevant to vascular aging, we have generated mice deficient in CHIP that have an impaired stress response and many features that are consistent with accelerated aging. We will now begin to explore the molecular events that link these processes in the present proposal. To do this, we propose four aims: Specific aim #1-- Determine the effects of CHIP deficiency on aging-related phenotypes; Specific aim #2-- Establish the cellular consequences of CHIP deficiency in vascular smooth muscle cells in vitro; Specific aim #3-- Determine the role of the cell stress regulation on vascular phenotypes and atherogenesis in vivo; Specific aim #4--- Examine the interactions of the chaperone
system with oxidative metabolism and IGF-1 signaling. These studies will create a portrait of the interactions between chaperone dysfunction, chronic oxidative injury, and alterations in IGF-1 signaling that determine the vascular response to aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CVD GENETIC PREDISPOSITIONS AND GENOMIC SIGNATURES
-
批准号:7882102
-
项目类别:
-
资助金额:$61.48万
-
财政年份:2010
-
负责人:WINSTON C PATTERSON
-
依托单位:
Signaling in Endothelial Growth and Angiogenesis
-
批准号:8217256
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
Signaling in Endothelial Growth and Angiogenesis
-
批准号:8019000
-
项目类别:
-
资助金额:$45.12万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
Signaling in Endothelial Growth and Angiogenesis
-
批准号:7822207
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
Signaling in Endothelial Growth and Angiogenesis
-
批准号:7526546
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
PROGRAM IN RACIAL DISPARITIES AND CARDIOVASCULAR DISEASE
-
批准号:7628154
-
项目类别:
-
资助金额:$56.0万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
Signaling in Endothelial Growth and Angiogenesis
-
批准号:7805617
-
项目类别:
-
资助金额:$51.06万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
Signaling in Endothelial Growth and Angiogenesis
-
批准号:7921329
-
项目类别:
-
资助金额:$5.94万
-
财政年份:2009
-
负责人:WINSTON C PATTERSON
-
依托单位:
PROGRAM IN RACIAL DISPARITIES AND CARDIOVASCULAR DISEASE
-
批准号:7888372
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2008
-
负责人:WINSTON C PATTERSON
-
依托单位:
PROGRAM IN RACIAL DISPARITIES AND CARDIOVASCULAR DISEASE
-
批准号:8133098
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2008
-
负责人:WINSTON C PATTERSON
-
依托单位:
UNC-Clinician-Scientist Training Program in Cardiovascular Medicine
-
批准号:8150795
-
项目类别:
-
资助金额:$24.69万
-
财政年份:2006
-
负责人:WINSTON C PATTERSON
-
依托单位:
UNC-Clinician-Scientist Training Program in Cardiovascular Medicine
-
批准号:8336890
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2006
-
负责人:WINSTON C PATTERSON
-
依托单位:
ADULT AND COMMUNITY HEALTH EARMARK
-
批准号:7402348
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2005
-
负责人:WINSTON C PATTERSON
-
依托单位:
ADULT AND COMMUNITY HEALTH EARMARK
-
批准号:7402349
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2005
-
负责人:WINSTON C PATTERSON
-
依托单位:
CHAPERONE FUNCTION AND VASCULAR AGING
-
批准号:6828192
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2004
-
负责人:WINSTON C PATTERSON
-
依托单位:
Carolina Cardiopulmonary Gene Expression Services
-
批准号:6571647
-
项目类别:
-
资助金额:$63.38万
-
财政年份:2002
-
负责人:WINSTON C PATTERSON
-
依托单位:
Carolina Cardiopulmonary Gene Expression Services
-
批准号:6665514
-
项目类别:
-
资助金额:$59.5万
-
财政年份:2002
-
负责人:WINSTON C PATTERSON
-
依托单位:
Aging, Stress and Atherosclerosis
-
批准号:6637091
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2002
-
负责人:WINSTON C PATTERSON
-
依托单位:
Carolina Cardiopulmonary Gene Expression Services
-
批准号:6779735
-
项目类别:
-
资助金额:$58.62万
-
财政年份:2002
-
负责人:WINSTON C PATTERSON
-
依托单位:
Carolina Cardiopulmonary Gene Expression Services
-
批准号:6919958
-
项目类别:
-
资助金额:$62.38万
-
财政年份:2002
-
负责人:WINSTON C PATTERSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: